D. E. Shaw & Co., Inc. - COLLEGIUM PHARMACEUTICAL INC ownership

COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 134 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q2 2018. The put-call ratio across all filers is 1.92 and the average weighting 0.2%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of COLLEGIUM PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2023$3,244,147
+35.2%
145,152
+30.0%
0.00%
+50.0%
Q2 2023$2,399,294
-30.9%
111,647
-22.8%
0.00%
-50.0%
Q1 2023$3,471,233
+521.5%
144,695
+501.0%
0.00%
+300.0%
Q4 2022$558,517
+54.7%
24,074
+6.7%
0.00%
Q3 2022$361,000
-16.4%
22,564
-7.4%
0.00%
-100.0%
Q2 2022$432,000
-83.8%
24,368
-81.4%
0.00%
-50.0%
Q1 2022$2,667,000
+19.7%
130,964
+9.8%
0.00%0.0%
Q4 2021$2,229,000
+144.9%
119,305
+158.9%
0.00%
+100.0%
Q3 2021$910,000
-17.7%
46,079
-14.3%
0.00%0.0%
Q4 2019$1,106,000
+101.1%
53,749
+12.1%
0.00%0.0%
Q3 2019$550,000
+133.1%
47,926
+167.2%
0.00%
Q2 2019$236,000
-88.6%
17,936
-86.9%
0.00%
-100.0%
Q1 2019$2,074,000
+195.0%
137,017
+365.2%
0.00%
+200.0%
Q2 2018$703,000
-75.0%
29,455
-73.2%
0.00%
-75.0%
Q1 2018$2,810,000
-33.0%
109,972
-51.6%
0.00%
-33.3%
Q4 2017$4,195,000
+167.9%
227,272
+52.3%
0.01%
+200.0%
Q3 2017$1,566,000
-16.0%
149,255
+0.2%
0.00%
-33.3%
Q2 2017$1,864,000
+29.1%
149,010
+3.9%
0.00%0.0%
Q1 2017$1,444,000
+310.2%
143,483
+640.3%
0.00%
+200.0%
Q1 2016$352,000
+30.4%
19,383
+97.7%
0.00%
Q4 2015$270,0009,8040.00%
Other shareholders
COLLEGIUM PHARMACEUTICAL INC shareholders Q2 2018
NameSharesValueWeighting ↓
Tejara Capital Ltd 289,803$6,477,0973.67%
Tamarack Advisers, LP 185,000$4,134,7502.68%
Rubric Capital Management LP 3,175,000$70,961,2502.66%
Eventide Asset Management 2,631,334$58,810,3151.06%
Camber Capital Management LP 1,050,000$23,4680.77%
EMERALD MUTUAL FUND ADVISERS TRUST 559,480$12,504,3780.76%
EMERALD ADVISERS, LLC 690,487$15,432,3800.75%
Values First Advisors, Inc. 43,507$972,3740.63%
AlphaCentric Advisors LLC 49,500$1,106,3250.63%
SummerHaven Investment Management, LLC 33,666$752,4350.55%
View complete list of COLLEGIUM PHARMACEUTICAL INC shareholders